Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Sparing of Organs at Risk in High Dose Rate Brachytherapy for Cervix Cancer

NCT01681342 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT01681342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01681342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Sparing of Organs at Risk in High Dose Rate Brachytherapy for Cervix Cancer
Lead sponsor
Centre Oscar Lambret
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
February 28, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical carcinoma stage ib to iv